About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 131 record(s)
Req # A-2021-000264
Adverse Drug Reaction (ADR) for Nicorandil. Report number: E2B_03625631.Organization: Health Canada
August 2021
Req # A-2021-000272
Adverse Drug Reaction (ADR) for Prevegyne. Report number: E2B_03212857.Organization: Health Canada
August 2021
Req # A-2021-000278
Adverse Reaction Reports (AERs) for Zostavax II. Report numbers: 000699750, 000699872, 000701516, 000701755, 000702222, 000702391, 000703037, E2B_00966671, E2B_01335934.Organization: Health Canada
August 2021
Req # A-2021-000285
Adverse Reaction Reports (AERs). Report numbers: E2B_02312117, E2B_02429456, E2B_02463007, E2B_02469221, E2B_02545370, E2B_02552675, E2B_02559270, E2B_02566708, E2B_02577847, E2B_02670994, 000730127, E2B_02644048, E2B_02732404, E2B_02748020, E2B_02748260, E2B_02755115, E2B_02755227, E2B_02755813, E2B_02755885, E2B_02756658.Organization: Health Canada
August 2021
Req # A-2021-000290
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106192-165, ASDM attending the Roadmap for Open Science Steering Committee.Organization: Health Canada
August 2021
Req # A-2021-000294
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105824-424, Ministerial joint meeting with SEUI/CUPE/Unifor.Organization: Health Canada
August 2021
Req # A-2021-000297
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105379-837.Organization: Health Canada
August 2021
Req # A-2021-000298
Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: 000927017.Organization: Health Canada
August 2021
Req # A-2021-000305
The brand name of the reference product and the dosage form of the generic submission under review for the medicinal ingredient Acyclovir.Organization: Health Canada
August 2021
Req # A-2021-000319
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103408-98.Organization: Health Canada
August 2021